Find a Clinical Trial
Filter
Takeda footprint
Neonatal care
All genders
Recruiting now
Department of Obstetrics + Gynecology
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Breast cancer, Locally advanced and metastatic breast cancer
All genders
Recruiting now
Cancer Center
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Non-small cell lung cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Division of Thoracic Surgery
TAP Block and minimally invasive hysterectomy for pain control
Uterine cancer
Female
Recruiting now
Department of Obstetrics + Gynecology
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
Small cell lung cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Breast Cancer Database
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
Recruiting now
Cancer Center
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
Recruiting now
Cancer Center